Lab-grown organoids mimic features of human body parts, leading to accelerated medical research while presenting new ethical questions.
By Acacia Gibbins
Mini-organs grown in labs are no longer science fiction. As organoids mimic the brain, liver, and even eyes, they’re reshaping how we approach medicine and forcing us into new ethical dilemmas.
What exactly is an organoid?
Organoids are small three-dimensional cell structures grown from stem cells that replicate key features of real organs. Unlike flat cell cultures, organoids self-organize into layered tissues that reassemble the structure and behaviour of organs such as the brain, liver, lungs, and intestines.
By re-creating organs, scientists can study disease, test new drugs, and investigate infections using tissue that behaves much more like the human body than traditional laboratory models. Organoids bridge the gap between animal testing and human trials, allowing researchers to observe how human cells respond in conditions that are almost lifelike.
Organoids and organ transplants
The global shortage of transplantable organs has driven scientists to explore whether organoids might one day act as replacements or repair tissue inside the body.
Researchers are working on growing tissue in laboratories that could potentially be used to repair damage, for example by producing liver tissue patches or intestinal grafts. While growing a complete, functioning human organ in a dish remains out of reach, scientists have successfully transplanted small organoid tissues into animals where they integrated and performed biological functions.
Better vaccines and immune modelling
Organoids are also transforming how vaccines are tested. Because they replicate human tissue more accurately than animal models, researchers can observe how viruses infect specific organs and how immune cells respond.
During the COVID-19 pandemic, lung and gut organoids helped researchers understand how SARS-CoV-2 attacked human tissue. Scientists can now test vaccines and antiviral drugs on organoids earlier and more safely, reducing reliance on animal testing and improving accuracy before trials begin in humans. This allows vaccines to be refined faster and tailored more precisely to human biology, potentially increasing both safety and effectiveness.
Personalized treatments
One of the greatest achievements of organoid technology is its impact on personalized medicine. Doctors can take a small biopsy from a patient’s tumour and grow a “mini-tumor” organoid in the lab. Multiple treatments can then be tested to see which drug works best for that individual.
This approach improves survival rates by identifying effective therapies more quickly and avoiding unnecessary side effects from drugs that may not work. Organoids are already being used in cancer treatment research and show promise.
Ethical, legal, and social questions
The rapid development of organoids presents unprecedented ethical challenges.
One major concern is whether brain organoids could ever develop consciousness. While current models are too simple to feel or think, advancing complexity raises questions about moral status and legal protection. For example, in the future, where should the line be drawn if brain organoids continue to develop unexpected structures such as eye-like tissues, or if organs are cloned from an individual’s DNA for transplantation? Furthermore, personalized organoid treatments risk widening global health inequalities if they remain expensive and limited to wealthy nations or patients.
So, are organoids the future?
Organoids are not just emerging technologies. They represent a shift in how medicine is practiced. From guiding treatment decisions to accelerating vaccine development and potentially solving organ shortages, their influence is growing rapidly.
However, progress must remain guided by strong ethical frameworks. As science constantly evolves, society must decide where innovation ends and responsibility begins, with ethics continually racing to keep up with discovery.
Organoids may not replace human organs and animal testing tomorrow, but they are already reshaping medicine today.
References
Farahany, N. A., Greely, H. T., Hyman, S., et al. (2018). The ethics of experimenting with human brain tissue. Nature, 556, 429–432. https://doi.org/10.1038/d41586-018-04813-x
Lancaster, M. A., & Knoblich, J. A. (2014). Organogenesis in a dish: Modeling development and disease using organoid technologies. Science, 343(6194). https://doi.org/10.1126/science.1247125
Mallapaty, S. (2025). Mini hearts, lungs and livers made in lab now grow their own blood vessels. Nature, 643, 892. https://doi.org/10.1038/d41586-025-02183-9
Vlachogiannis, G., Hedayat, S., Vatsiou, A., et al. (2018). Patient-derived organoids model treatment response of metastatic gastrointestinal cancers. Science, 359(6378), 920–926. https://doi.org/10.1126/science.aao2774
Featured image is Madison Wilson, a PhD student at UC San Diego who co-authored a 2022 study showing that human brain organoids implanted in mice have established functional connectivity to the animals’ cortex and responded to external sensory stimuli. Credit: David Baillot/UC San Diego on Flickr, licensed as CC BY 2.0.
About the Author
Acacia Gibbins is an undergraduate Biomedical Science in the UK with a passion for science communication, sustainability and innovation. She enjoys translating complex research into engaging stories that explore how emerging technologies shape both medicine and society. When she’s not studying, Acacia is often making art or contributing graphic design work for nonprofit organizations.
